Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SBC Medical Group Holdings (SBC) EBIT Margin (2023 - 2025)

Historic EBIT Margin for Medical Group Holdings (SBC) over the last 3 years, with Q3 2025 value amounting to 36.63%.

  • Medical Group Holdings' EBIT Margin rose 105700.0% to 36.63% in Q3 2025 from the same period last year, while for Sep 2025 it was 33.26%, marking a year-over-year decrease of 68500.0%. This contributed to the annual value of 34.23% for FY2024, which is 22800.0% down from last year.
  • Medical Group Holdings' EBIT Margin amounted to 36.63% in Q3 2025, which was up 105700.0% from 33.57% recorded in Q2 2025.
  • Medical Group Holdings' EBIT Margin's 5-year high stood at 51.39% during Q2 2024, with a 5-year trough of 10.62% in Q4 2024.
  • Over the past 3 years, Medical Group Holdings' median EBIT Margin value was 38.48% (recorded in 2023), while the average stood at 37.21%.
  • Its EBIT Margin has fluctuated over the past 5 years, first crashed by -278500bps in 2024, then soared by 105700bps in 2025.
  • Over the past 3 years, Medical Group Holdings' EBIT Margin (Quarter) stood at 38.48% in 2023, then crashed by -72bps to 10.62% in 2024, then skyrocketed by 245bps to 36.63% in 2025.
  • Its EBIT Margin was 36.63% in Q3 2025, compared to 33.57% in Q2 2025 and 51.14% in Q1 2025.